These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 560884

  • 1. Lithium inhibition of norepinephrine and dopamine receptors.
    Flemenbaum A.
    Biol Psychiatry; 1977 Aug; 12(4):563-72. PubMed ID: 560884
    [Abstract] [Full Text] [Related]

  • 2. Chronic lithium treatment and dopamine-mediated behavior.
    Ebstein RP, Eliashar S, Belmaker RH, Ben-Uriah Y, Yehuda S.
    Biol Psychiatry; 1980 Jun; 15(3):459-67. PubMed ID: 7189675
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Behavioral effects of chronic apomorphine, and D-1/D-2 dopamine receptor activities in rats].
    Minematsu N.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Jun; 15(3):247-52. PubMed ID: 7584718
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Roxindole: psychopharmacological profile of a dopamine D2 autoreceptor agonist.
    Bartoszyk GD, Harting J, Minck KO.
    J Pharmacol Exp Ther; 1996 Jan; 276(1):41-8. PubMed ID: 8558454
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Interactions between agents stimulating and inhibiting the central dopamine receptors and octopamine.
    Jagiełło-Wójtowicz.
    Acta Physiol Pol; 1980 Jan; 31(2):153-8. PubMed ID: 6771963
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Relationship between self-administration of amphetamine and monoamine receptors in brain: comparison with cocaine.
    Ritz MC, Kuhar MJ.
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1010-7. PubMed ID: 2703961
    [Abstract] [Full Text] [Related]

  • 14. Studies on the participation of the dopaminergic system in the central effects of chelidonine.
    Kleinrok Z, Szponar J, Matuszek B, Jagiełło-Wójtowicz E.
    Pol J Pharmacol Pharm; 1990 Mar; 42(5):417-24. PubMed ID: 2098751
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Central antiserotonergic and antidopaminergic action of pirenperone, a putative 5-HT2 receptor antagonist.
    Pawłowski L, Siwanowicz J, Bigajska K, Przegaliński E.
    Pol J Pharmacol Pharm; 1985 Mar; 37(2):179-96. PubMed ID: 4048012
    [Abstract] [Full Text] [Related]

  • 19. Cocaine acts on accumbens monoamines and locomotor behavior via a 5-HT2A/2C receptor mechanism as shown by ketanserin: 24-h follow-up studies.
    Broderick PA, Olabisi OA, Rahni DN, Zhou Y.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):547-57. PubMed ID: 15093963
    [Abstract] [Full Text] [Related]

  • 20. Interaction of drugs with apomorphine, tryptamine and norepinephrine. A new 'in vivo' approach: the ATN-test in rats.
    Niemegeers CJ, Lenaerts FM, Artois KS, Janssen PA.
    Arch Int Pharmacodyn Ther; 1977 Jun; 227(2):238-53. PubMed ID: 20857
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.